{
    "2019-01-04": [
        [
            {
                "time": "2019-01-03",
                "original_text": "Bristol To Become Top 5 Pharma â€” And Other Fallout From Celgene Takeover",
                "features": {
                    "keywords": [
                        "Bristol",
                        "Top 5 Pharma",
                        "Celgene Takeover"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-01-03",
                "original_text": "Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "BMY",
                        "CELG",
                        "MRK",
                        "NASH Candidate"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-03",
                "original_text": "Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration",
                "features": {
                    "keywords": [
                        "Nektar",
                        "ImaginAb",
                        "Immuno-Oncology",
                        "Collaboration"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-04",
                "original_text": "Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "FLKS",
                        "NVAX",
                        "ESPR",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-04",
                "original_text": "Pfizer Begins Pivotal Study on Alopecia Areata Candidate",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Pivotal Study",
                        "Alopecia Areata"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-04",
                "original_text": "Pfizer Rises 3%",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Rises",
                        "3%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-04",
                "original_text": "Today's Research Reports on Trending Tickers: Pfizer and Bristol-Myers Squibb",
                "features": {
                    "keywords": [
                        "Research Reports",
                        "Trending Tickers",
                        "Pfizer",
                        "Bristol-Myers Squibb"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}